Arm Stock Falls After HSBC Downgrade, Citing Limited Near-Term AI Upside 
Jamie Dimon Warns Anthropic's Mythos AI Poses National Security Risks 
Apple Intelligence China Approval Lifts Alibaba and Baidu Shares 
BHP Faces Major Port Hedland Strike as Labor Talks Stall Ahead of Production Report 
ASML Raises 2026 Outlook as AI Chip Demand Lifts Q2 Earnings 
Volkswagen Launches €28,000 ID. Cross EV as Europe’s Electric Vehicle Demand Accelerates 
Stripe, Advent Offer Over $53 Billion to Acquire PayPal in Major Fintech Deal 
BHP Q4 Iron Ore Output Rebounds as Copper Prices Boost Revenue 
Paramount-Warner Bros. Discovery Merger Faces Lawsuit From 12 States 
Taiwan Mangoes Head to Europe as Premium Fruit Exports Expand 
Apple Intelligence Cleared for China as Alibaba and Baidu AI Power iPhone Features 
xAI Sues Man for Allegedly Using Grok to Generate AI Child Abuse Deepfakes 
SK Hynix Stock Soars as AI Memory Demand Outlook Fuels Chip Rally 
DBS Targets S$1 Trillion Wealth AUM by 2030 Amid Asia Wealth Boom 
SpaceX Stock Falls Below IPO Price as Investors Weigh Losses and Lockup Expiry 
Alibaba Stock Jumps as China Approves Apple Intelligence Powered by Qwen AI 
Rio Tinto Reports Strong Q2 Iron Ore Sales, Maintains 2026 Production Outlook 
BEDFORD, Mass., Jan. 27, 2016 -- ConforMIS, Inc. (NASDAQ:CFMS) announced today that it will host a conference call on Thursday, February 11, 2016, at 4:30 p.m. Eastern Time to discuss its financial results for the fourth quarter and fiscal year ended December 31, 2015. To participate in the conference call, please call 877-703-9876 (or 616-548-5612 for international) and use conference ID number 35700545.
The conference call will be hosted by Philipp Lang, MD, MBA, President and Chief Executive Officer, and Paul Weiner, Chief Financial Officer. The company will issue a news release announcing its fourth quarter and fiscal year 2015 financial results, and financial guidance for fiscal year 2016 on Thursday, February 11, 2016, prior to the conference call.
A live webcast of the conference call will also be available in the investor relations section of the company’s website at ir.conformis.com. The online archive of the webcast will be available on the company’s website for 30 days.
About ConforMIS, Inc.
ConforMIS is a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are individually sized and shaped, or customized, to fit each patient’s unique anatomy. ConforMIS offers a broad line of customized knee implants and pre-sterilized, single-use instruments delivered in a single package to the hospital. In recent clinical studies, ConforMIS iTotal CR demonstrated superior clinical outcomes, including better function and greater patient satisfaction, compared to traditional, off-the-shelf implants. ConforMIS owns or exclusively in-licenses approximately 500 issued patents and pending patent applications that cover customized implants and patient-specific instrumentation for all major joints.
For more information, visit www.conformis.com. To receive future releases in e-mail alerts, sign up at http://www.ir.conformis.com.
Contacts Investor Contact: Oksana Bradley [email protected] (781) 374-5598
